NCT06519474 Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
| NCT ID | NCT06519474 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 17 participants |
| Start Date | 2024-07-10 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 17 participants in total. It began in 2024-07-10 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effects of elastic chest compression on functional exercise capacity and respiratory performance of patients with COPD. The main questions it aims to answer are: Is there difference in functional exercise capacity and respiratory performance without or with the use of elastic upper chest compression? Is there difference in functional exercise capacity and respiratory performance between the use of elastic upper chest compression and elastic lower chest compression? Participants will: Be evaluated under three conditions on three different days: without elastic compression, with upper chest compression, and with lower chest compression, with the order of compression application randomly assigned. The functional capacity and respiratory muscle performance of all patients will be evaluated. The days for evaluation will be at least three days apart from each other.
Eligibility Criteria
Inclusion Criteria: * at least 20 years old * has a clinical diagnosis of COPD without infection or acute exacerbation in the previous four weeks * is capable of cooperating with the required tests and measurements of the study Exclusion Criteria: * has any clinical diagnosis that could affect test outcomes (e.g., neuromyopathy) * has experienced unstable angina or an acute myocardial infarction within the last month * has adjusted COPD related medication within the last month * a Mini-Mental State Examination (MMSE) score below 24
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06519474 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06519474 currently recruiting?
Yes, NCT06519474 is actively recruiting participants. Contact the research team at G00997@hch.gov.tw for enrollment information.
Where is the NCT06519474 trial being conducted?
This trial is being conducted at Hsinchu, Taiwan.
Who is sponsoring the NCT06519474 clinical trial?
NCT06519474 is sponsored by National Taiwan University Hospital. The trial plans to enroll 17 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.